Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Îòîðèíîëàðèíãîëîãèÿ > Îáùåíèå ñïåöèàëèñòîâ

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 27.08.2008, 14:16
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âîïðîñ ïðî àíòèáèîòèêè - íàçíà÷àòü èëè íåò.

Çäðàâñòâóéòå!

Îá èññëåäîâàíèÿõ, äèàãíîçå.

Òàêèå ëàá. èññëåäîâàíèÿ êàê ÑÎÝ, êîë-âî ëåêîöèòîâ è Ñ ðåàêòèâíûé áåëîê ìîãóò áûòü ïîëåçíûìè ïðè äèàãíîñòèêå ÎÑÒÐÎÃÎ ñèíóñèòà, îäíàêî ðåàëüíî ÿâëÿþòñÿ âòîðè÷íûìè è íåîáÿçàòåëüíûìè.

Ïîñåâ íà êóëüòóðó âîçáóäèòåëÿ íå ïðîâîäèòñÿ ðóòèííî ïðè ïîäîçðåíèè íà îñòðûé ñèíóñèò. Òîëüêî ó áîëüíûõ, ïîëó÷àþùèõ èììóíîñóïðåññèâíîå ëå÷åíèå, ÂÈ×.

Ðåíòãåíèññëåäîâàíèÿ íåîáÿçàòåëüíû â íåçàâèñèìîñòè îò âåðîÿòíîñòè îñòðîãî ñèíóñèòà (âûñîêàÿ, íèçêàÿ). Îäíàêî, ïîëåçíû ïðè ñîìíåíèÿõ â äèàãíîçå, íàïðèìåð î ëîêàëèçàöèè...
Íåäîñòàòîê ðåíòãåíñíèìêîâ â îãðàíè÷åííîì ïîëå âèäèìîñòè, íåâîçìîæíîñòè îòëè÷èòü èíôåêöèþ îò ïîëèïîâ èëè îïóõîëè, ìàëîå ðàçðåøåíèå ýòìîèäàëüí è ñôåíîèäàëüí. ñèíóñîâ.
ÊÒ òàêæå íå ñïåöèôè÷íî íè ïî îòíîøåíèþ ê äèàãíîçó, íè ê ëå÷åíèþ, ïðèìåíÿåòñÿ ÷àùå äëÿ âûÿñíåíèÿ äåòàëåé, ó áîëüíûõ çàïëàíèðîâàííûõ íà õèðóðãèþ, â ñëó÷àå îñëîæíåíèé èò.ä.

 ñëó÷àå ñ õðîíè÷åñêèì ñèíóñèòîì ðîëü ðåíòãåíà òàê æå ìàëà. Ïîçâîëÿåò ëèøü "óâèäåòü" ïàòîëîãèþ â ôðîíòàëüíîé è ìàêñèëÿðíîé îáëàñòÿõ.

Íåêîíòðàñòíàÿ òîìîãðàôèÿ ÿâÿåòñÿ íà ñåãîäíÿ íàèáîëåå ýôôåêòèâíîé äëÿ óòî÷íåíèÿ äåòàëåé àíàòîìèè è âûÿâëåíèÿ ïðèçíàêîâ ïàòîëîãèè.

Òàêæå òðàäèöèîííî áåðåòñÿ ïîñåâ ïîñðåäñòâîì ïóíêöèè.

Íåñêîëüêî ñëîâ î ëå÷åíèè.

 ñëó÷àå ñ îñòðûì ïðîöåññîì, íàçíà÷àþòñÿ àíòèáèîòèêè ( àìîêñèöèëëèí, êëàðèòðîìèöèí, àçèòðîìèöèí - ïåðâàÿ ëèíèÿ) â ñîîòâ. ñ íàèáîëåå ÷àñòûìè âîçáóäèòåëÿìè íà 2 íåäåëè.
Òàêæå öåëÿìè ëå÷åíèÿ ÿâëÿþòñÿ - ñíèçèòü âûðàæåííîñòü ñèìïòîìîâ, îáåñïå÷èòü äîëæíûé äðåíàæ è ïðåäîòâðàòèòü îñëîæåíèÿ.

 ñëó÷àå õðîíè÷åñêîãî ïðîöåññà.
Íàçíà÷åíèå àíòèáèîòèêîâ íà 3-4 íåäåëè, êàê ïðàâèëî â ñîîòâåòñòâèè ñ ðåçóëüòàòàìè ïîñåâà è ÷óâñòâèòåëüíîñòè âîçáóäèòåëÿ.  îáùåì ïåðâîé ëèíèåé ñ÷èòàåòñÿ àìîêñèöèëèí ïëþñ êëàâóàíîâàÿ êèñëîòà è âòîðîå ïîêîëåíèå öåôàëîñïîðèíîâ (öåôóðîêñèì).
  #2  
Ñòàðûé 27.08.2008, 14:21
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
2 ENT.

Èñòî÷íèêè, ðåêîìåíäóþ îçíàêîìèòüñÿ.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
  #3  
Ñòàðûé 27.08.2008, 16:31
Àâàòàð äëÿ ENT_1
ENT_1 ENT_1 âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.07.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,066
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 378 ðàç(à) çà 355 ñîîáùåíèé
ENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âî-ïåðâûõ, ñ ýòèìè èñòî÷íèêàìè ÿ çíàêîìà. Âî-âòîðûõ, â Âàøèõ öèòàòàõ åñòü ïðîòèâîðå÷èÿ.
Â-òðåòüèõ, äëÿ òîãî, ÷òîáû âûëå÷èòü ñèíóñèò (êàêîé èìåííî íå óòî÷íÿþ), íå äîñòàòî÷íî ïðî÷èòàòü ñòàòüè ïî ýòîé òåìå. Íóæíî èìåòü îïûò ñîâìåùåíèÿ òåîðèè ñ ïðàêòèêîé.
Âñå, ÷òî Âû ïðîöèòèðîâàëè ñàìî ïî ñåáå ïðàâèëüíî, òîëüêî ýòó èíôîðìàöèþ íóæíî ïðàâèëüíî ïðèìåíèòü. È â Ðîññèè òàêòèêà äèàãíîñòèêè è ëå÷åíèÿ ñèíóñèòîâ ñîâïàäàåò ñ çàðóáåæíîé. (âîïðîñ ïóíêöèè áóäåò îçâó÷åí ïîçæå)
 ñëó÷àå îñòðîãî ñèíóñèòà, êîòîðûé ìîæåò èìåòü êàê âèðóñíóþ, òàê è áàêòåðèàëüíóþ ýòèîëîãèþ, â áîëüøèíñòâå ñëó÷àåâ ðåíòãåíîäèàãíîñòèêà íå ïðîâîäèòñÿ, à ëå÷åíèå ìîæåò áûòü ëèøü ñèìïòîìàòè÷åñêîå è äîñòàòî÷íî âåëèê ïðîöåíò âûçäîðîâèëèâàþùèõ.  Ðîññèè òàêèå ïàöèåíòû îáðàùàþòñÿ ê òåðàïåâòó è ñ äèàãíîçîì "ÎÐÂÈ" èäóò ëå÷èòüñÿ äîìîé. Åñëè â ðåçóëüòàòå ëå÷åíèÿ íå íàñòóïàåò óëó÷øåíèÿ, ëèáî ïîñëå óëó÷øåíèÿ, íàñòóïàåò óõóäøåíèå (ó áîëüíîãî ñîõðíÿþòñÿ ñèìïòîìû ñèíóñèòà), òî âðà÷, ïîäîçðåâàÿ ïðèñîåäèíåíèå áàêòåðèàëüíîé ôëîðû, íàçíà÷àåò êóðñ àíòèáàêòåðèàëüíîé òåðàïèè ïåðâîé ëèíèè. Åñëè è ýòî íå ïîìîãàåò â òå÷åíèå 7 äíåé, òî áîëüíîé íàïðàâëÿåòñÿ ê ËÎÐó äëÿ ïîäòâåðæäåíèÿ äèàãíîçà ñèíóñèò, è íå ïðîñòî ïîäòâåðæäåíèÿ, à äëÿ îïðåäåëåíèÿ ëîêàëèçàöèè ïðîöåññà. Îñòðûé ñèíóñèò ðàçäåëÿåòñÿ íà ãàéìîðèò, ýòìîèäèò, ôðîíòèò, ñôåíîèäèò è íàêîíåö, ïàíñèíóñèò. Ïîñëåäíèå òðè äèàãíîçà ñ÷èòàþòñÿ áîëåå îïàñíûìè, ò.ê. ðèñê îñëîæíåíèé âûøå.
"Acute frontal sinusitis is considered a more serious type of acute sinus infection because of its complications."

Ïðè ñîìíèòåëüíûõ æàëîáàõ, íåòèïè÷íîé êëèíè÷åñêîé êàðòèíå, ËÎÐ-âðà÷ îáÿçàí ïðîâåñòè ðåíòãåíîäèàãíîñòèêó äëÿ óòî÷íåíèÿ äèàãíîçà.

"When a patient begins to have headache, confusion, and eyelid pain, concern for the complications of frontal sinusitis should arise. Radiologic studies, especially coronal and axial paranasal CT scan or MRI, can be diagnostic."
The role of imaging in acute frontal sinusitis is to establish its extent and help depict any orbital or intracranial complications. Conventional radiography, consisting of the acquisition of Caldwell, Waters, lateral, and submentovertex views, is mainly of historical interest because of the current widespread availability of more sophisticated imaging modalities (ie, CT scanning and MRI)."
 Ðîññèéñêèõ ãîðîäñêèõ áîëüíèöàõ è ïîëèêëèíèêàõ, ê ñîæàëåíèþ, íå âñåãäà åñòü âîçìîæíîñòü ïðîèçâåñòè ÊÒ ÎÍÏ, ïîýòîìó ÷àùå ïðèáåãàþò ê ðåíòãåíîãðàôèè.
CT scanning is the imaging study of chThe sphenoid
sinus can be visualized with plain film radiography by
including a base or submentovertex viewoice because it depicts optimal bony, soft tissue, and air detail in the setting of sinus disease.

×òî êàñàåòñÿ ñôåíîèäèòà, êîòîðûé òàê æå ÿâëÿåòñÿ îñòðûì ñèíóñèòîì:
"Patients with acute sphenoid sinusitis often present with vague nonlocalizing symptoms. Headache is the most common symptom; almost all patients in various studies complain of headache. Although the vertex headache is classic, the pain also can be retroorbital, parietooccipital, or frontal."

 78% ñëó÷àåâ îí îñòàåòñÿ misdiagnosed.

Êàê òîëüêî äèàãíîç ïîñòàâëåí, à îí ñòàâèòñÿ òîëüêî íà îñíîâàíèè ÊÒ ÎÍÏ (ïðè ïðàâèëüíî âûïîëíåííîé ðåíòãåíîãðàôèè, ñôåíîèäèò òàê æå âèäåí "The sphenoid sinus can be visualized with plain film radiography by
including a base or submentovertex view"), íåçàìåäëèòåëüíî íà÷èíàåòñÿ êîìïëåêñíàÿ êîíñåðâàòèâíàÿ òåðàïèÿ. "start medical treatment of acute sphenoid sinusitis once the diagnosis is made. Institute antibiotics and decongestants for 24 hours, and, if the patient does not improve over this time course, schedule surgical therapy."

Ðåíòãåíîäèàãíîñòèêà îñòðîãî ñèíóñèòà ïðîâîäèòñÿ òîãäà, êîãäà íåäîñòàòî÷íî êëèíè÷åñêèõ ñèìïòîìîâ è åñòü ñîìíåíèÿ â äèàãíîçå.
Imaging studies are not necessary when the probability of sinusitis is either high or low but may be useful when the diagnosis is in doubt, based upon a thorough history and physical examination.

Ê ñîæàëåíèþ, â ïîñëåäíèå ãîäû âñå ÷àùå âîçíèêàþò ñèíóñèòû ñ íåòèïè÷íîé êëèíè÷åñêîé êàðòèíîé (òî åñòü íå ïî ó÷åáíèêó).

Êàêîâà æå öåëü ëå÷åíèÿ ñèíóñèòîâ? 1. ýðàäèêàöèÿ âîçáóäèòåëÿ 2. îáåñïå÷åíèå àäåêâàòîíîãî äðåíàæà ïîðàæåííîé ïàçóõè 3. ïðåäóïðåæäåíèå ðàçâèòèÿ îñëîæíåíèé
Îñòàíîâèìñÿ íà ïóíêòå 2. Àäåêâàòíûé äðåíàæ ïîðàæåííîé ïàçóõè ìîæíî îáåñïå÷èòü êàê ìåäèêàìåíòîçíûì, òàê è õèðóðãè÷åñêèì ñïîñîáîì. Ìåäèêàìåíòîçíûé - ìåñòíûå, ñèñòåìíûå äåêîíãåñòàíòû (àíåìèçàöèÿ ñëèçèñòîé îáîëî÷êè â ìåñòå íàõîæäåíèÿ ñîóñòüÿ), èíîãäà àíòèãèñòàìèíû, ìåñòíûå è ñèñòåìíûå êîðòèêîñòåðîèäû. Õèðóðãè÷åñêèé ñïîñîá - ïóíêöèÿ (ó íàñ ýòî ñ÷èòàåòñÿ êîíñåðâàòèâíûì) âåðõíå÷åëþñòíîé ïàçóõè è ýíäîñêîïè÷åñêèå îïåðàöèè íà ïàçóõàõ FESS. ×òî êàñàåòñÿ ïóíêöèè, òî çàðóáåæîì ê íåé ïðèáåãàþò ïðè íåýôôåêòèâíîñòè êîíñåðâàòèâíîé òåðàïèè: "Sinus puncture and irrigation techniques allow for a surgical means of removal of thick purulent sinus secretions. The purpose of surgical drainage is to enhance mucociliary flow and provide material for culture and sensitivity. A surgical means of sinus drainage should be used when appropriate medical therapy has failed to control the infection and prolonged or slowly resolving symptoms result or when complications of sinusitis occur."

 Ðîññèè ìû êîìïëåêñíî ïîäõîäèì ê ëå÷åíèþ îñòðîãî ãàéìîðèòà: îáåñïå÷èâàÿ äðåíàæ êàê ìåäèêàìåíòîçíûì, òàê è èíâàçèâíûì ñïîñîáîì. Ïóíêöèÿ ïî ñóòè - òà æå îïåðàöèÿ. Ïîýòîìó ýòî çà÷àñòóþ ïîçâîëÿåò èçáåæàòü áîëåå ñåðüåçíîãî âìåøàòåëüñòâà íà ïàçóõàõ ñ ðàñøèðåíèåì ñîóñòüåâ, óäàëåíèåì êðþ÷êîâèäíîãî îòðîñòêà è ò.ä. (FESS) ïîä íàðêîçîì.
Ïî÷åìó çàðóáåæîì íå èñïîëüçóþò ïóíêöèþ ðóòèííî ïðè ãíîéíûõ ãàéìîðèòàõ - ïî ýêîíîìè÷åñêèì ñîîáðàæåíèÿì. Îá ýòîì ÿ ïèñàëà, ìîè ñëîâà ïîäòâåðäèë ïðàêòèêóþùèé ËÎÐ èç Ãåìàíèè. Ïîñêîëüêó ýêîíîìè÷åñêèå ïðåäïîñûëêè âîçíèêëè äàâíî, ìíîãèõ ïðîñòî ýòîìó íå ó÷àò.
No absolute contraindications to maxillary sinus drainage exist. Íåò àáñîëþòíûõ ïðîòèâîïîêàçàíèé äëÿ ïóíêöèè, êðîìå íàðóøåíèÿ ñâåðòûâàåìîñòè êðîâè è ïîäîáíîå.

Íåñìîòðÿ íà òî, ÷òî ïóíêöèè ïðèìåíÿþòñÿ ðåäêî, åå âñå åùå íàçûâàþò çîëîòûì ñòàíäàðòîì.
"Prospective series looking at antral puncture results as
the gold standard showed complete opacification, and airfluid
level, or both, on plain film radiography to have a
sensitivity of 0.73 and specificity of 0.80 for acute rhinosinusitis."

Ïî ïîâîäó ñèíóñèòîâ ìîæíî ðàññóæäàòü î÷åíü ìíîãî, âñå öèòàòû áûëè âçÿòû èç ñòàòåé emedicine è ïîñëåäíèõ àìåðèêàíñêèõ ðåêîìåíäàöèé ïî ñèíóñèòàì. À âîò ýòà öèòàòà, ÿâëÿåòñÿ íàâåðíîå ñàìîé âàæíîé, íàäåþñü Âû ïîéìåòå åå ñóòü:
As medical knowledge expands and technology advances,
clinical indicators and guidelines are promoted as conditional
and provisional proposals of what is recommended
under specific conditions, but they are not absolute. Guidelines
are not mandates and do not and should not purport to
be a legal standard of care. The responsible physician, in
light of all the circumstances presented by the individual
patient, must determine the appropriate treatment. Adherence
to these guidelines will not ensure successful patientoutcomes in every situation. The American Academy of
Otolaryngology–Head and Neck Surgery (AAO-HNS), Inc.
emphasizes that these clinical guidelines should not be
deemed inclusive of all proper treatment decisions or methods
of care, or exclusive of other treatment decisions or
methods of care reasonably directed to obtaining the same
results.

Óâàæàåìûå êîëëåãè, î÷åíü áîëüøàÿ ïðîñüáà âñå íåîäîáðåíèÿ ïîäðîáíî àðãóìåíòèðîâàòü íå ïðîñòî ññûëêàìè èëè îòäåëüíî âçÿòûìè ôðàçàìè, âûðâàííûìè èç êîíòåêñòà (êîòîðûå ñàìè ïî ñåáå áóäóò íàâåðíîå ïðàâèëüíûìè), à ïðåäëàãàÿ ñâîé âàðèàíò ðåøåíèÿ ïðîáëåìû. Òîëüêî â ýòîì ñëó÷àå íàø äèàëîã áóäåò êîíñòðóêòèâíûì.
  #4  
Ñòàðûé 27.08.2008, 17:19
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Áîëüøàÿ ïðîñüáà ê ENT_1 âñå âûäåðæêè íà àíãë. ïîäòâåðæäàòü ññûëêàìè íà èñòî÷íèê, ÷òî òàêæå áóäåò ïîëåçíî â ïëàíå îçíàêîìëåíèÿ ñ íîâîé èíôîðìàöèåé.
Ïî ïîâîäó "âûðûâàíèé" îòäåëüíûõ ôðàç èç êîíòåêñòà, ýòî áîëåå ïðèìåíèòåëüíî ê Âàøåìó ïîñëåäíåìó ïîñòó.

Öèòàòà:
Ñîîáùåíèå îò ENT_1 Ïîñìîòðåòü ñîîáùåíèå
Âî-ïåðâûõ, ñ ýòèìè èñòî÷íèêàìè ÿ çíàêîìà.
Ýòî òîëüêî ðàäóåò.

Öèòàòà:
Âî-âòîðûõ, â Âàøèõ öèòàòàõ åñòü ïðîòèâîðå÷èÿ.
Ãäå æå?

Öèòàòà:
Â-òðåòüèõ, äëÿ òîãî, ÷òîáû âûëå÷èòü ñèíóñèò (êàêîé èìåííî íå óòî÷íÿþ), íå äîñòàòî÷íî ïðî÷èòàòü ñòàòüè ïî ýòîé òåìå. Íóæíî èìåòü îïûò ñîâìåùåíèÿ òåîðèè ñ ïðàêòèêîé.
Ñòàòüÿ äîêòîð äëÿ Âàñ è êàê ïîäòâåðæäåíèå íàïèñàííîé ðåêîìåíäàöèè.
Ïðàêòèêîâàòü è ïðàêòèêîâàòü ïðàâèëüíî, ê ñîæàëåíèþ íå îäíî è òî æå.

Öèòàòà:
Âñå, ÷òî Âû ïðîöèòèðîâàëè ñàìî ïî ñåáå ïðàâèëüíî, òîëüêî ýòó èíôîðìàöèþ íóæíî ïðàâèëüíî ïðèìåíèòü.
Íå î÷åíü ïîíÿòíî âûðàæåíèå. À êàê ïðèìåíèòü íåïðàâèëüíî?

Öèòàòà:
È â Ðîññèè òàêòèêà äèàãíîñòèêè è ëå÷åíèÿ ñèíóñèòîâ ñîâïàäàåò ñ çàðóáåæíîé. (âîïðîñ ïóíêöèè áóäåò îçâó÷åí ïîçæå)
Ïîêà íå çàìåòèë.

Öèòàòà:
 ñëó÷àå îñòðîãî ñèíóñèòà, êîòîðûé ìîæåò èìåòü êàê âèðóñíóþ, òàê è áàêòåðèàëüíóþ ýòèîëîãèþ, â áîëüøèíñòâå ñëó÷àåâ ðåíòãåíîäèàãíîñòèêà íå ïðîâîäèòñÿ, à ëå÷åíèå ìîæåò áûòü ëèøü ñèìïòîìàòè÷åñêîå è äîñòàòî÷íî âåëèê ïðîöåíò âûçäîðîâèëèâàþùèõ.
Ñîãëàñåí.
Öèòàòà:
Åñëè â ðåçóëüòàòå ëå÷åíèÿ íå íàñòóïàåò óëó÷øåíèÿ, ëèáî ïîñëå óëó÷øåíèÿ, íàñòóïàåò óõóäøåíèå (ó áîëüíîãî ñîõðíÿþòñÿ ñèìïòîìû ñèíóñèòà), òî âðà÷, ïîäîçðåâàÿ ïðèñîåäèíåíèå áàêòåðèàëüíîé ôëîðû, íàçíà÷àåò êóðñ àíòèáàêòåðèàëüíîé òåðàïèè ïåðâîé ëèíèè.
Êàê áû íå ñîâñåì ñîãëàñåí ñ ïðèñîåäèíåíèåì ÷åãî ëèáî êóäà ëèáî, íî â öåëîì ìîæåò áûòü.

Öèòàòà:
Åñëè è ýòî íå ïîìîãàåò â òå÷åíèå 7 äíåé,
Ñîððè, àíòèáèîòèê íàçíà÷àåòñÿ íà 14 äíåé.



Öèòàòà:
Ïðè ñîìíèòåëüíûõ æàëîáàõ, íåòèïè÷íîé êëèíè÷åñêîé êàðòèíå, ËÎÐ-âðà÷ îáÿçàí ïðîâåñòè ðåíòãåíîäèàãíîñòèêó äëÿ óòî÷íåíèÿ äèàãíîçà.
×òî äàñò ðåíòãåí? ×òî âðà÷ íà íåì óâèäèò? Ãäå ýòî íàïèñàíî?

Öèòàòà:
"When a patient begins to have headache, confusion, and eyelid pain, concern for the complications of frontal sinusitis should arise. Radiologic studies, especially coronal and axial paranasal CT scan or MRI, can be diagnostic."
Çäåñü î ÊÒ è ÌÐÒ ðå÷ü... Êñòàòè èñòî÷íèê?

Öèòàòà:
 78% ñëó÷àåâ îí îñòàåòñÿ misdiagnosed.
Èñòî÷íèê?

Öèòàòà:
Êàê òîëüêî äèàãíîç ïîñòàâëåí, à îí ñòàâèòñÿ òîëüêî íà îñíîâàíèè ÊÒ ÎÍÏ (ïðè ïðàâèëüíî âûïîëíåííîé ðåíòãåíîãðàôèè, ñôåíîèäèò òàê æå âèäåí "The sphenoid sinus can be visualized with plain film radiography by
including a base or submentovertex view"), íåçàìåäëèòåëüíî íà÷èíàåòñÿ êîìïëåêñíàÿ êîíñåðâàòèâíàÿ òåðàïèÿ.
Äèàãíîç ñòàâèòñÿ ðàíåå è êëèíè÷åñêè. Ýòè ìåòîäû, ÊÒ, ïîìîãàþò ëèøü ëîêàëèçîâàòü ïðîöåññ.

Öèòàòà:
Ðåíòãåíîäèàãíîñòèêà îñòðîãî ñèíóñèòà ïðîâîäèòñÿ òîãäà, êîãäà íåäîñòàòî÷íî êëèíè÷åñêèõ ñèìïòîìîâ è åñòü ñîìíåíèÿ â äèàãíîçå.

Imaging studies are not necessary when the probability of sinusitis is either high or low but may be useful when the diagnosis is in doubt, based upon a thorough history and physical examination.
Ñîððè, íî ñòîèò áîëåå òî÷íî ïåðåâîäèòü, âûäóìûâàòü íå íóæíî.
Ðåíòãåí (õîòÿ ðå÷ü è î äðóãèõ âèçóàëèçèð. èññëåäîâàíèÿõ) íå îáÿçàòåëüíû âíå çàâèñèìîñòè îò òîãî âåðîÿòíîñòü íàëè÷èÿ ñèíóñèòà âûñîêà èëè íèçêà, íî ìîãóò áûòü ïîëåçíû êîãäà äèàãíîç ïîä ñîìíåíèåì, è îñíîâàí ëèøü íà èñòîðèè çàáîëåâàíèÿ è ôèçèêàëüíîì îñìîòðå.
Ãëàâíûå ñëîâà: íå îáÿçàòåëüíû, ìîãóò áûòü ïîëåçíû.

Öèòàòà:
Ê ñîæàëåíèþ, â ïîñëåäíèå ãîäû âñå ÷àùå âîçíèêàþò ñèíóñèòû ñ íåòèïè÷íîé êëèíè÷åñêîé êàðòèíîé (òî åñòü íå ïî ó÷åáíèêó).
Èñòî÷íèê, ïðèìåðû, ïðîöåíò ðàçâèòèÿ îò îáùåãî ÷èñëà?


Öèòàòà:
Îñòàíîâèìñÿ íà ïóíêòå 2. Àäåêâàòíûé äðåíàæ ïîðàæåííîé ïàçóõè ìîæíî îáåñïå÷èòü êàê ìåäèêàìåíòîçíûì, òàê è õèðóðãè÷åñêèì ñïîñîáîì. Ìåäèêàìåíòîçíûé - ìåñòíûå, ñèñòåìíûå äåêîíãåñòàíòû (àíåìèçàöèÿ ñëèçèñòîé îáîëî÷êè â ìåñòå íàõîæäåíèÿ ñîóñòüÿ), èíîãäà àíòèãèñòàìèíû, ìåñòíûå è ñèñòåìíûå êîðòèêîñòåðîèäû.
 öåëîì ñîãëàñåí, òîëüêî íå íóæíî ñâàëèâàòü âñå â îäíó êó÷ó.
Äåêîíãåñòàíòû òîëüêî êîðîòêèìè êóðñàìè, íå áîëåå 3-5 äíåé.
Ñòåðîèäû â ñëó÷àå îñòðîãî ïðîöåññà íå ïîêàçàëè óáåäèòåëüíîé ýôôåêòèâíîñòè.
Àíòèãèñòàìèííûå ïðåïàðàòû ìîãóò áûòü íàçíà÷åíû òîëüêî ó áîëüíûõ âêóïå ñ àëëåðãè÷åñêèì ðèíèòîì, ðóòèííî íå íàçíà÷àþòñÿ.

Öèòàòà:
Õèðóðãè÷åñêèé ñïîñîá - ïóíêöèÿ (ó íàñ ýòî ñ÷èòàåòñÿ êîíñåðâàòèâíûì) âåðõíå÷åëþñòíîé ïàçóõè è ýíäîñêîïè÷åñêèå îïåðàöèè íà ïàçóõàõ FESS. ×òî êàñàåòñÿ ïóíêöèè, òî çàðóáåæîì ê íåé ïðèáåãàþò ïðè íåýôôåêòèâíîñòè êîíñåðâàòèâíîé òåðàïèè:

"Sinus puncture and irrigation techniques allow for a surgical means of removal of thick purulent sinus secretions. The purpose of surgical drainage is to enhance mucociliary flow and provide material for culture and sensitivity. A surgical means of sinus drainage should be used when appropriate medical therapy has failed to control the infection and prolonged or slowly resolving symptoms result or when complications of sinusitis occur."
Ýòî ïðèìåð âûðâàííîãî èç êîíòåêñòà êóñêà òåêñòà.

Âîò êàê ýòî íàïèñàíî â îðèãèíàëå.

Öèòàòà:
Sinus puncture and irrigation techniques allow for a surgical means of removal of thick purulent sinus secretions. The purpose of surgical drainage is to enhance mucociliary flow and provide material for culture and sensitivity. A surgical means of sinus drainage should be used when appropriate medical therapy has failed to control the infection and prolonged or slowly resolving symptoms result or when complications of sinusitis occur. Another indication for sinus puncture is to obtain culture material to guide antibiotic selection if empiric therapy has failed or antibiotic choice is limited. This is particularly important in patients who are immunocompromised or in intensive care. Sinusitis can be a prominent source of sepsis in these patients. In adults, sinus puncture can usually be achieved using local anesthesia; however, in children, a general anesthetic is usually necessary.
" êîãäà òåðàïåâòè÷. ëå÷åíèå íå ñïðàâëÿåòñÿ ñ êîíòðîëåì èíôåêöèè, èëè èäåò î÷åíü ìåäëåííîå ðàçðåøåíèå (èçëå÷åíèå) ñèìïòîìîâ, èëè â ñëó÷àå îñëîæíåíèé.
Äðóãîå ïîêàçàíèå äëÿ ïóíêöèè - ïîëó÷åíèå êóëüòóðû äëÿ âûáîðà àíòèáèîòèêà, åñëè ýìïèðè÷åñêàÿ òåðàïèÿ íå ýôôåêòèâíà èëè âûáîð àíòèáèîòèêà îãðàíè÷åí. Ýòî â ÷àñòíîñòè âàæíî ó èììóíîêîìïðîìåíòèðîâàííûõ ïàöèåíòîâ, èëè â ðåàíèìàöèè." èò.ä.

ß äóìàþ åñòü ðàçíèöà...


Öèòàòà:
 Ðîññèè ìû êîìïëåêñíî ïîäõîäèì ê ëå÷åíèþ îñòðîãî ãàéìîðèòà:
Íå ãîâîðèòå çà âñþ Ðîññèþ... ýòî êàê áû íåñêîëüêî ñàìîóâåðåííî...

Öèòàòà:
Ïî÷åìó çàðóáåæîì íå èñïîëüçóþò ïóíêöèþ ðóòèííî ïðè ãíîéíûõ ãàéìîðèòàõ - ïî ýêîíîìè÷åñêèì ñîîáðàæåíèÿì. Îá ýòîì ÿ ïèñàëà, ìîè ñëîâà ïîäòâåðäèë ïðàêòèêóþùèé ËÎÐ èç Ãåìàíèè. Ïîñêîëüêó ýêîíîìè÷åñêèå ïðåäïîñûëêè âîçíèêëè äàâíî, ìíîãèõ ïðîñòî ýòîìó íå ó÷àò.
Ýòî íå ñîâñåì òàê. Íà ïåðâîì ìåñòå ìåäèöèíñêàÿ öåëåñîîáðàçíîñòü, à íå ýêîíîìèêà. Ïîâåðüòå.

Öèòàòà:
Íåñìîòðÿ íà òî, ÷òî ïóíêöèè ïðèìåíÿþòñÿ ðåäêî, åå âñå åùå íàçûâàþò çîëîòûì ñòàíäàðòîì.
"Prospective series looking at antral puncture results as
the gold standard showed complete opacification, and airfluid
level, or both, on plain film radiography to have a
sensitivity of 0.73 and specificity of 0.80 for acute rhinosinusitis."
Èñòî÷íèê?

Öèòàòà:
Ïî ïîâîäó ñèíóñèòîâ ìîæíî ðàññóæäàòü î÷åíü ìíîãî, âñå öèòàòû áûëè âçÿòû èç ñòàòåé emedicine è ïîñëåäíèõ àìåðèêàíñêèõ ðåêîìåíäàöèé ïî ñèíóñèòàì.
Ýòî ñëîâà... íå áîëåå.

Öèòàòà:
À âîò ýòà öèòàòà, ÿâëÿåòñÿ íàâåðíîå ñàìîé âàæíîé, íàäåþñü Âû ïîéìåòå åå ñóòü:
As medical knowledge expands and technology advances,
clinical indicators and guidelines are promoted as conditional
and provisional proposals of what is recommended
under specific conditions, but they are not absolute. Guidelines
are not mandates and do not and should not purport to
be a legal standard of care. The responsible physician, in
light of all the circumstances presented by the individual
patient, must determine the appropriate treatment. Adherence
to these guidelines will not ensure successful patientoutcomes in every situation. The American Academy of
Otolaryngology–Head and Neck Surgery (AAO-HNS), Inc.
emphasizes that these clinical guidelines should not be
deemed inclusive of all proper treatment decisions or methods
of care, or exclusive of other treatment decisions or
methods of care reasonably directed to obtaining the same
results.
 öåëîì äà. Òîëüêî ýòî íå äàåò ïðàâà ËÎÐ âðà÷ó ëå÷èòü èìåííî òàê êàê îí õî÷åò, âíå ãàéäîâ è ñòàíäàðòîâ. Õîòÿ îïÿòü æå, èñòî÷íèê?

Êîììåíòàðèè ê ñîîáùåíèþ:
áðóêñà îäîáðèë(à): Ïðàêòèêîâàòü è ïðàêòèêîâàòü ïðàâèëüíî íå îäíî è òîæå.
  #5  
Ñòàðûé 27.08.2008, 19:10
ArakancevUV ArakancevUV âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.06.2008
Ãîðîä: ã. Âîëæñêèé
Ñîîáùåíèé: 532
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 79 ðàç(à) çà 76 ñîîáùåíèé
ArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûå äîêòîðà!Ìíå êàæåòñÿ,÷òî Âàøà àêàäåìè÷åñêàÿ ïîëåìèêà èíòåðåñíà ïàöèåíòó,íî îíà íå íåñ¸ò äëÿ íåãî íèêàêîé êîíêðåòíîé èíôîðìàöèè(ïîìîùè,çà êîòîðîé îíà îáðàòèëàñü).Åñëè ðåíòãåí,êàê Âû ñ÷èòàåòå,íå íåñ¸ò íèêàêîé èíôîðìàöèè,òî äàéòå åé ÏÐÀÊÒÈ×ÅÑÊÈÅ ðåêîìåíäàöèè,êîòîðûå îíà ÆÄ¨Ò ÎÒ ÂÀÑ(à íå òåîðåòè÷åñêèå ðàññóæäåíèÿ î ëå÷åíèè î.è õð.ñèíóñèòîâ ïðåïàðàòàìè ïåðâîé èëè âòîðîé ëèíèè). ñïîðàõ íå íàäî çàáûâàòü î áîëüíîì.
  #6  
Ñòàðûé 27.08.2008, 19:41
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ArakancevUV Ïîñìîòðåòü ñîîáùåíèå
Óâàæàåìûå äîêòîðà!Ìíå êàæåòñÿ,÷òî Âàøà àêàäåìè÷åñêàÿ ïîëåìèêà èíòåðåñíà ïàöèåíòó,íî îíà íå íåñ¸ò äëÿ íåãî íèêàêîé êîíêðåòíîé èíôîðìàöèè(ïîìîùè,çà êîòîðîé îíà îáðàòèëàñü).Åñëè ðåíòãåí,êàê Âû ñ÷èòàåòå,íå íåñ¸ò íèêàêîé èíôîðìàöèè,òî äàéòå åé ÏÐÀÊÒÈ×ÅÑÊÈÅ ðåêîìåíäàöèè,êîòîðûå îíà ÆÄ¨Ò ÎÒ ÂÀÑ(à íå òåîðåòè÷åñêèå ðàññóæäåíèÿ î ëå÷åíèè î.è õð.ñèíóñèòîâ ïðåïàðàòàìè ïåðâîé èëè âòîðîé ëèíèè). ñïîðàõ íå íàäî çàáûâàòü î áîëüíîì.
Ñîððè, à, Âû, êîëëåãà, Ñåáÿ óæå èñ÷åðïàëè? Ðåêîìåíäàöèè áûëè äàíû.
  #7  
Ñòàðûé 27.08.2008, 20:48
ArakancevUV ArakancevUV âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.06.2008
Ãîðîä: ã. Âîëæñêèé
Ñîîáùåíèé: 532
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 79 ðàç(à) çà 76 ñîîáùåíèé
ArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåArakancevUV ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íåò,êîëëåãà.Ïðîñòî ðàáîòàþ ÿ â ãëóáîêîé ïðîâèíöèè ÐÔ,ãäå ïðèâûêëè ó÷èòûâàòü ðåçóëüòàòû ðåíòãåíà(à äðóãîãî îáñëåäîâàíèÿ çäåñü ïðîñòî íåò) è ëå÷àò çäåñü â áîëüøèíñòâå ñâî¸ì(ìîæåò ýòî è íå ñîâñåì ïðàâèëüíî)îïèðàÿñü íå íà çàðóá.ãàéäû,à íà ðîññèéñêèå ðåêîìåíäàöèè è ñîáñòâåííûé îïûò(êàê çåìñêèå âðà÷è).Ïîýòîìó,âïîëíå ñåðü¸çíî,ÿ "çàìîë÷àë",ò.ê. ïîäóìàë,÷òî òîëêó îò Âàøèõ ðåêîìåíäàöèé áóäåò áîëüøå,÷åì îò ìîèõ.Íå íàâðåäè.PS:ïîëó÷èë ìíîãî ïîëåçíîé èíôîðìàöèè.Èñêðåííåå ñïàñèáî.
  #8  
Ñòàðûé 27.08.2008, 21:52
Àâàòàð äëÿ ENT_1
ENT_1 ENT_1 âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.07.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,066
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 378 ðàç(à) çà 355 ñîîáùåíèé
ENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé äîêòîð Morphey, êàæäîå ñëîâî â ìîåì ñîîáùåíèè áûëî ïîäòâåðæäåíî âûäåðæêàìè èç èñòî÷íèêîâ è ñòàòåé, ññûëêè íà êîòîðûå Âû ñàìè ìíå è ïðèñûëàëè è êàæåòñÿ, ÷òî Âû èõ íå ÷èòàåòå. Âîò ññûëêè, ïîæàëóéñòà ÷èòàéòå âíèìàòåëüíî, òàì Âû íàéäåòå âñå ìîè öèòàòû.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

 öåëîì, âñå Âàøè îòâåòû íà ìîè ïîñòû, â òîì ÷èñëå ïðî ÿêîáû íåòî÷íûé ïåðåâîä, ïî ñìûñëó àáñîëþòíî ñîâïàäàþò ñ òåì, ÷òî íàïèñàëà ÿ. Ïîýòîìó óäèâëåíà âàøåé êðèòèêîé è íåæåëàíèåì ïðèçíàòü î÷åâèäíîå. (èíôîðìàöèþ, âçÿòóþ ñ ñàéòà emedicine.com). Èíîãäà Âû ïðîñòî ðàñøèôðîâûâàëè ìîè âûäåðæêè (ÿ ïîñ÷èòàëà, ÷òî ýòî áóäåò èçëèøíèì). Âñå ïðîñüáû î ïðèâåäåíèè ññûëîê áóäóò óäîâëåòâîðåíû, êàê òîëüêî Âû âñå ïðî÷èòàåòå (èìåþ ââèäó ïðèâåäåííûå âûøå ññûëêè).
Ðåíòãåíîäèàãíîñòèêà - ýòî íå òîëüêî áàíàëüíûé íåíàâèñòíûé Âàì ðåíòãåí, ýòî åùå è ðåíòãåíîâñêàÿ êîìïüþòåðíàÿ òîìîãðàôèÿ.
Òî, ÷òî äèàãíîç ñòàâèòñÿ ðàíåå êëèíè÷åñêè, à âåðíåå ïðåäïîëàãàåòñÿ, òî ýòî ïîíÿòíî. Ñ êàêîé ñòàòè âðà÷ áóäåò íàçíà÷àòü ðåíòãåí ëèáî ÊÒ, åñëè îí íå ïðåäïîëàãàåò äèàãíîç. Ýòî î÷åâèäíî.
Äàëåå, ãäå Âû ïðî÷èòàëè, ÷òî ËÎÐ-âðà÷ ëå÷èò âíå ãàéäîâ è ñòàíäàðòîâ. Êàê ÿ ïèñàëà â ïåðâîì ïîñòå, îí ëå÷èò â ñîîòâåòñòâèè ñ ðîññèéñêèìè ñòàíäàðòàìè, êîòîðûå ïî ñóòè ñâîåé ñîâïàäàþò ñ åâðîïåéñêèìè, òîëüêî èìåþò ðàçíûå íàçâàíèÿ. Òîãäà, ñëåäóÿ Âàøåé ëîãèêå, íåïðîôèëüíûé âðà÷, êåì ÿâëÿåòåñü Âû, âîîáùå íå èìååò ïðàâî äàâàòü ñîâåòû ïàöèåíòó.

È íàêîíåö, êàñàòåëüíî Âàøèõ ðåêîìåíäàöèé, êàê Âû èçâîëèëè èñïðàâèòü â ìîåì ïîñòå ïðîäîëæèòåëüíîñòü êóðñà àíòèáèîòèêà âìåñòî 7 íà 14 äíåé, òî â óêàçàííîé ññûëêå, êàñàþùåéñÿ ôðîíòèòà ñêàçàíî (à ÿ ãîâîðèëà î ôðîíòèòå) ,÷òî åñëè íà 3-5-é äåíü ïðèåìà àíòèáèîòèêà íå íàñòóïàåò íèêàêîãî óëó÷øåíèÿ, òî ñëåäóåò ëèáî åãî ïîìåíÿòü, ëèáî ïðèáåãíóòü ê õèðóðãè÷åñêîé îïåðàöèè.
Ê òîìó æå àçèòðîìèöèí (êîòîðûé Âû ïîðåêîìåíäîâàëè ïàöèåíòó, à ïîòîì óäàëèëè èç ñâîåãî ïîñòà) íàçíà÷àåòñÿ íà 3 - ìàêñèìóì 5 äíåé, à íå íà 14, êàê âû ïîðåêîìåíäîâàëè. È åñëè ãîâîðèòü î ðîññèéñêîé ñïåöèôèêå, òî â îòîëàðèíãîëîãèè åãî íàçíà÷àþò ðåäêî, ïîñêîëüêó î÷åíü ìíîãî ôàëüñèôèêàòà, äà è ïðîäîëæèòåëüíîñòü êóðñà íå ïîäõîäèò.
Óâàæàåìûå êîëëåãè, ïåðâûå ñâîè ïîñòû íà ýòîì ôîðóìå, ÿ íå ïîäêðåïëÿëà ññûëêàìè. Ïîñëå ãîðÿ÷èõ íàøèõ ñ Âàìè äèñêóññèé, ÿ óÿñíèëà, ÷òî äëÿ òîãî, ÷òîáû ñîîòâåòñòâîâàòü ôîðìàòó ôîðóìà, íóæíî ñâîè ñëîâà àðãóìåíòèðîâàòü ñ ïðèâåäåíèåì ññûëîê èç óâàæàåìûõ èñòî÷íèêîâ.
Âñå ññûëêè, êîòîðûå Âû ìíå íàñòîÿòåëüíî ðåêîìåíäîâàëè ïðî÷èòàòü (â áîëüøèíñòâå ñëó÷àåâ åìåäèñí, ÿ äåòàëüíî èçó÷èëà è ñîïîñòàâèëà ñ ðîññèéñêîé ïðàêòèêîé, è ê äàæå ñâîåìó óäèâëåíèþ ïîíÿëà, ÷òî âñå ïî ñóòè ñîâïàäàåò, íî èìååò ðàçíûå íàçâàíèÿ è ñâîþ ñïåöèôèêó. Ïîýòîìó ìíå íåïîíÿòíî, ïî÷åìó âàñ íå óñòðàèâàþò ìîè îòâåòû, êîòîðûå ïîëíîñòüþ ïîäòâåðæäàþòñÿ çàðóáåæíûìè èñòî÷íèêàìè, íà êîòîðûå âû îïèðàåòåñü ñàìè.

Êîììåíòàðèè ê ñîîáùåíèþ:
Gilarov îäîáðèë(à):
  #9  
Ñòàðûé 27.08.2008, 22:33
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ENT_1 Ïîñìîòðåòü ñîîáùåíèå
Óâàæàåìûé äîêòîð Morphey, êàæäîå ñëîâî â ìîåì ñîîáùåíèè áûëî ïîäòâåðæäåíî âûäåðæêàìè èç èñòî÷íèêîâ è ñòàòåé, ññûëêè íà êîòîðûå Âû ñàìè ìíå è ïðèñûëàëè è êàæåòñÿ, ÷òî Âû èõ íå ÷èòàåòå. Âîò ññûëêè, ïîæàëóéñòà ÷èòàéòå âíèìàòåëüíî, òàì Âû íàéäåòå âñå ìîè öèòàòû.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Àãà, çà ïîñëåäíþþ ñïàñèáî, ïðî÷òó, â ïðîöåññå.

Öèòàòà:
 öåëîì, âñå Âàøè îòâåòû íà ìîè ïîñòû, â òîì ÷èñëå ïðî ÿêîáû íåòî÷íûé ïåðåâîä, ïî ñìûñëó àáñîëþòíî ñîâïàäàþò ñ òåì, ÷òî íàïèñàëà ÿ.
Íå ñîâñåì. Âû èìåííî âûðûâàëè èç êîíòåêñòà, à íå ïåðåâîäèëè. Íî îñòàâèì.

Öèòàòà:
Ïîýòîìó óäèâëåíà âàøåé êðèòèêîé è íåæåëàíèåì ïðèçíàòü î÷åâèäíîå.
Åñòü òàêîå ïðåä÷óâñòâèå, ÷òî óäèâëÿòüñÿ Âû áóäåòå åùå íå ðàç.

Öèòàòà:
(èíôîðìàöèþ, âçÿòóþ ñ ñàéòà emedicine.com). Èíîãäà Âû ïðîñòî ðàñøèôðîâûâàëè ìîè âûäåðæêè (ÿ ïîñ÷èòàëà, ÷òî ýòî áóäåò èçëèøíèì). Âñå ïðîñüáû î ïðèâåäåíèè ññûëîê áóäóò óäîâëåòâîðåíû, êàê òîëüêî Âû âñå ïðî÷èòàåòå (èìåþ ââèäó ïðèâåäåííûå âûøå ññûëêè).
Ýòî óñëîâèå, èëè Âû ñî ìíîé èãðàåòå?

Öèòàòà:
Ðåíòãåíîäèàãíîñòèêà - ýòî íå òîëüêî áàíàëüíûé íåíàâèñòíûé Âàì ðåíòãåí, ýòî åùå è ðåíòãåíîâñêàÿ êîìïüþòåðíàÿ òîìîãðàôèÿ.
Äà? Ñïàñèáî çà ðàçúÿñíåíèå, à òî áû òàê äóðàêîì è æèë äàëüøå.
Êñòàòè, êòî Âàì ñêàçàë, ÷òî ÿ íåíàâèæó ðåíòãåí? Âàñ îáìàíóëè, æåñòîêî.

Öèòàòà:
Òî, ÷òî äèàãíîç ñòàâèòñÿ ðàíåå êëèíè÷åñêè, à âåðíåå ïðåäïîëàãàåòñÿ, òî ýòî ïîíÿòíî. Ñ êàêîé ñòàòè âðà÷ áóäåò íàçíà÷àòü ðåíòãåí ëèáî ÊÒ, åñëè îí íå ïðåäïîëàãàåò äèàãíîç. Ýòî î÷åâèäíî.
Ïîíÿòíî, î÷åâèäíî, íî íå ýòî. ß ïèñàë î íåäîñòàòêàõ ðåíòãåíà è ïûòàëñÿ ïîÿñíèòü ïî÷åìó ýòîò ìåòîä íå äîëæåí èñïîëüçîâàòüñÿ ðóòèííî.
È ïðàâäà, êàê íà ðàçíûõ ÿçûêàõ "ãîâîðèì".

Öèòàòà:
Äàëåå, ãäå Âû ïðî÷èòàëè, ÷òî ËÎÐ-âðà÷ ëå÷èò âíå ãàéäîâ è ñòàíäàðòîâ.
Ýòîò âûâîä ìîæíî ñäåëàòü êîíêðåòíî î Âàñ èñõîäÿ èç íàïèñàííîãî Âàìè æå.
Öèòàòà:
Êàê ÿ ïèñàëà â ïåðâîì ïîñòå, îí ëå÷èò â ñîîòâåòñòâèè ñ ðîññèéñêèìè ñòàíäàðòàìè, êîòîðûå ïî ñóòè ñâîåé ñîâïàäàþò ñ åâðîïåéñêèìè,
Íå çàìåòèë òî÷åê "ñîâïàäåíèÿ". Ñîððè, âèäèìî ïëîõî ñìîòðåë, áóäó ïûòàòüñÿ åùå.

Öèòàòà:
òîëüêî èìåþò ðàçíûå íàçâàíèÿ.
Ýòî òî÷íî, ñîâñåì ðàçíûå.
Öèòàòà:
Òîãäà, ñëåäóÿ Âàøåé ëîãèêå, íåïðîôèëüíûé âðà÷, êåì ÿâëÿåòåñü Âû, âîîáùå íå èìååò ïðàâî äàâàòü ñîâåòû ïàöèåíòó.
Äîêòîð, áîëüíûå ñ ñèíóñèòàìè èçíà÷àëüíî ïîïàäàþò êî ìíå, è òîëüêî â ñëó÷àå ìîåãî íåïðàâèëüíîãî ëå÷åíèÿ âåðíåå íåóñïåõà, ê Âàì. Ýòî ïåðåôðàçèðóÿ ïðîôèëüíûõ è íåïðîôèëüíûõ âðà÷åé.

Öèòàòà:
È íàêîíåö, êàñàòåëüíî Âàøèõ ðåêîìåíäàöèé, êàê Âû èçâîëèëè èñïðàâèòü â ìîåì ïîñòå ïðîäîëæèòåëüíîñòü êóðñà àíòèáèîòèêà âìåñòî 7 íà 14 äíåé, òî â óêàçàííîé ññûëêå, êàñàþùåéñÿ ôðîíòèòà ñêàçàíî (à ÿ ãîâîðèëà î ôðîíòèòå) ,÷òî åñëè íà 3-5-é äåíü ïðèåìà àíòèáèîòèêà íå íàñòóïàåò íèêàêîãî óëó÷øåíèÿ, òî ñëåäóåò ëèáî åãî ïîìåíÿòü, ëèáî ïðèáåãíóòü ê õèðóðãè÷åñêîé îïåðàöèè.
Âî ïåðâûõ, îòêóäà Âû âçÿëè, ÷òî ó áîëüíîé èìåííî ôðîíòèò? Ýòî åùå íåèçâåñòíî. Ïîêà ìû èìååì äåëî ñ ñèíóñèòîì, íå áîëåå. Áîëüíàÿ íå ïðèíèìàëà àíòèáèîòèê 5 äíåé, ïîä âîïðîñîì è òå òðè...

Öèòàòà:
Ê òîìó æå àçèòðîìèöèí (êîòîðûé Âû ïîðåêîìåíäîâàëè ïàöèåíòó, à ïîòîì óäàëèëè èç ñâîåãî ïîñòà) íàçíà÷àåòñÿ íà 3 - ìàêñèìóì 5 äíåé, à íå íà 14, êàê âû ïîðåêîìåíäîâàëè.
Ýòî Âû ãäå òàêîå ïðî÷ëè?
Öèòàòà:
È åñëè ãîâîðèòü î ðîññèéñêîé ñïåöèôèêå, òî â îòîëàðèíãîëîãèè åãî íàçíà÷àþò ðåäêî, ïîñêîëüêó î÷åíü ìíîãî ôàëüñèôèêàòà, äà è ïðîäîëæèòåëüíîñòü êóðñà íå ïîäõîäèò.
Êàê ðàç íàîáîðîò. Àçèòðîìèöèí íàèáîëåå äåøåâûé èç ìàêðîëèäîâ è êàê ïîääåëûâàþò åãî ðåæå..

Öèòàòà:
Âñå ññûëêè, êîòîðûå Âû ìíå íàñòîÿòåëüíî ðåêîìåíäîâàëè ïðî÷èòàòü (â áîëüøèíñòâå ñëó÷àåâ åìåäèñí, ÿ äåòàëüíî èçó÷èëà è ñîïîñòàâèëà ñ ðîññèéñêîé ïðàêòèêîé, è ê äàæå ñâîåìó óäèâëåíèþ ïîíÿëà, ÷òî âñå ïî ñóòè ñîâïàäàåò, íî èìååò ðàçíûå íàçâàíèÿ è ñâîþ ñïåöèôèêó. Ïîýòîìó ìíå íåïîíÿòíî, ïî÷åìó âàñ íå óñòðàèâàþò ìîè îòâåòû, êîòîðûå ïîëíîñòüþ ïîäòâåðæäàþòñÿ çàðóáåæíûìè èñòî÷íèêàìè, íà êîòîðûå âû îïèðàåòåñü ñàìè.
Âû óâåðåíû, ÷òî Âû âñå ïðàâèëüíî ïîíÿëè è ïåðåâåëè. Ìîæåò ó íàñ ñ Âàìè ðàçíûå "Emedicine"s.??? Õîòÿ ýòî åùå äàëåêî íå âñå èñòî÷íèêè.
Èç Âàøèõ ñîâåòîâ è îòâåòîâ ýòîãî ïîêà çàìåòíî íå áûëî. Íî ïðîãðåññ íàëèöî.
  #10  
Ñòàðûé 27.08.2008, 22:58
Àâàòàð äëÿ ENT_1
ENT_1 ENT_1 âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.07.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,066
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 378 ðàç(à) çà 355 ñîîáùåíèé
ENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âàøè îòâåòû íà ìîè ïîñòû (ðåïëèêè è ýìîöèè) íèêàê íå âÿæóòñÿ ñ äèñêóññèåé ïðèâåðæåíöåâ äîêàçàòåëüíîé ìåäèöèíû, è ñîâåðøåííî íå â ôîðìàòå âðà÷åáíûõ äèñêóññèé. Ê òîìó æå ÿ âàì íå ïîäðóæêà, ÷òîáû îòâå÷àòü â ïîäîáíîì ôàìèëüÿðíîì èëè äàæå âûñîêîìåðíîì òîíå.

"Âî ïåðâûõ, îòêóäà Âû âçÿëè, ÷òî ó áîëüíîé èìåííî ôðîíòèò? Ýòî åùå íåèçâåñòíî. Ïîêà ìû èìååì äåëî ñ ñèíóñèòîì, íå áîëåå."
Åñëè ñèíóñèò è ôðîíòèò äëÿ Âàñ ðàçíûå ïîíÿòèÿ, òî òîãäà ìû òî÷íî ãîâîðèì íà ðàçíûõ ÿçûêàõ.

Ðåæèì äîçèðîâàíèÿ ( àçèòðîìèöèí)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Óñòàíàâëèâàþò èíäèâèäóàëüíî ñ ó÷åòîì íîçîëîãè÷åñêîé ôîðìû, òÿæåñòè òå÷åíèÿ çàáîëåâàíèÿ è ÷óâñòâèòåëüíîñòè âîçáóäèòåëÿ. Âçðîñëûì âíóòðü íàçíà÷àþò 0.25-1 ã 1 ðàç/ñóò; äåòÿì - 5-10 ìã/êã 1 ðàç/ñóò. Ïðîäîëæèòåëüíîñòü ïðèåìà 2-5 äíåé.
ëèáî ñìîòðèòå [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
  #11  
Ñòàðûé 27.08.2008, 23:24
Àâàòàð äëÿ áðóêñà
áðóêñà áðóêñà âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 12.03.2005
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 3,887
Ïîáëàãîäàðèëè 101 ðàç(à) çà 94 ñîîáùåíèé
áðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåáðóêñà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ENT_1 Ïîñìîòðåòü ñîîáùåíèå
Äàëåå, ãäå Âû ïðî÷èòàëè, ÷òî ËÎÐ-âðà÷ ëå÷èò âíå ãàéäîâ è ñòàíäàðòîâ. Êàê ÿ ïèñàëà â ïåðâîì ïîñòå, îí ëå÷èò â ñîîòâåòñòâèè ñ ðîññèéñêèìè ñòàíäàðòàìè, êîòîðûå ïî ñóòè ñâîåé ñîâïàäàþò ñ åâðîïåéñêèìè, òîëüêî èìåþò ðàçíûå íàçâàíèÿ.
Íàñêîëüêî ìíå èçâåñòíî eMedicine àìåðèêàíñêèé ðåñóðñ. Ïîñëåäíÿÿ ññûëêà - â ôîðìàòå ïäô-ôàéëà - òîæå àìåðèêàíñêîãî ïðîèñõîæäåíèÿ. Ìû ïåðåêëþ÷èëèñü íà Åâðîïó? Îçâó÷üòå òîãäà õîòü îäèí åâðîïåéñêèé äîêóìåíò, íà îñíîâàíèè êîòîðîãî Âû ïðèøëè ê òàêîìó âûâîäó.

Ïî ïîâîäó ñòàíäàðòîâ.. ß íå èíòåðåñîâàëàñü, ñóùåñòâóþò ëè îòå÷åñòâåííûå ñòàíäàðòû ïî ëå÷åíèþ ñèíóñèòîâ, íî åñëè ñóùåñòâóþò - ñòàíäàðòû íå îñíîâàííûå íà êëèíè÷åñêèõ èññëåäîâàíèÿõ è íå îáíîâëÿåìûå ðåãóëÿðíî åñòü çëî, áîëüøåå çëî, ÷åì èõ îòñóòñòâèå. Òàêîãî áûòü íå äîëæíî. Çàðóáåæíûå "ãàéäû" è ñòàíäàðòû ïîòîìó íàñòîëüêî è ïîïóëÿðíû â äàííîì ñëó÷àå íà ýòîì ðåñóðñå (ñðåäè òåõ, êòî è íå îáÿçàí èì ñëåäîâàòü)- ÷òî îíè ÿâëÿþòñÿ íàó÷íî-îáîñíîâàííûìè (ñîìíèòåëüíûå äèññåðòàöèè è è ìíåíèÿ "øêîë" ñþäà íå îòíîñÿòñÿ) è ðåãóëÿðíî ïåðåñìàòðèâàþòñÿ.

Íàâåðíîå âñå-òàêè áóäåò ÷åñòíûì îáúÿñíèòü ñâîå ìíåíèå ïî ïîâîäó Rg-ãðàôèè ïðèäàòî÷íûõ ïàçóõ íîñà, õîòü ýòî è íåïðîôèëüíàÿ äëÿ ìåíÿ òåìà. Ìîå ìíåíèå íå ïîäêðåïëåíî íèêàêîé ëèòåðàòóðîé, ýòî ìîå ëè÷íîå ìíåíèå, ãîòîâà ïðèçíàòü è îáíàðóæèòü íåêîìïåòåíòíîñòü ïåðåä âñåìè - ÿ íå ñ÷èòàþ ðåíòãåíîãðàôèþ ïàçóõ íîñà íàñòîëüêî íåíóæíîé è íåïðèåìëåìîé. Âî-ïåðâûõ ïîòîìó, ÷òî íà òåððèòîðèè íàøåé ñòðàíû àêòèâíî ïðèìåíÿåòñÿ ïóíêöèÿ âåðõíå÷åëþñòíîé ïàçóõè. ß íå ñ÷èòàþ, ÷òî ïóíêöèþ íåîáõîäèìî äåëàòü êàæäîìó âñòðå÷íîìó-ïîïåðå÷íîìó è ÷òî-ëèáî îòòóäà âûìûâàòü è ñåÿòü. Íî ïðè íàëè÷èè óðîâíÿ ãíîÿ, ýâàêóàöèÿ åãî èç ïàçóõè ïðèíîñèò ïàöèåíòó îáëåã÷åíèå (ïî êðàéíåé ìåðå ìîãó ñäåëàòü òàêîé âûâîä èç ñâîåé íåáîãàòîé êëèíè÷åñêîé ïðàêòèêè), ÷òî äëÿ ìåíÿ ÿâëÿåòñÿ äîñòàòî÷íûì îñíîâàíèåì äëÿ åå ïðîâåäåíèÿ. À ïîêàçàíèÿ ê ïóíêöèè ìîæíî îïðåäåëèòü èìåííî ðåíòãåíîãðàôèåé ïðèä. ïàçóõ íîñà. Âî-âòîðûõ - äëÿ óòî÷íåíèÿ äèàãíîçà (íàïð. òîïè÷åñêîé äèàãíîñòèêè) - íå âñåãäà îòå÷åñòâåííûé äîêòîð èìååò âîçìîæíîñòü íà÷àòü èññëåäîâàíèå ñ ÊÒ. ×àñòî äëÿ òîãî, ÷òîáû îáîñíîâàòü íàçíà÷åíèå ÊÒ (èëè ðåêîìåíäàöèþ), íóæíî ïðåäúÿâèòü Rg-ãðàììó, îáîñíîâàòü, ÷òî ýòîò ìåòîä èññëåäîâàíèÿ îêàçàëñÿ íåèíôîðìàòèâåí - íå âñåãäà òàêîå ïðèñóòñòâóåò, íî áûâàåò.  òðåòüèõ - îïÿòü æå âîïðîñ þðèäè÷åñêèé. Rg-ãðàììà ïðèäàòî÷íûõ ïàçóõ íîñà ýòî äîêóìåíò â èñòîðèè áîëåçíè, îòâå÷àþùèé íà âîïðîñû "à áûë ëè ìàëü÷èê", "à ÷òî âû ëå÷èëè".
Äðóãîå äåëî, ÷òî Rg-ãðàôèÿ ïðèäàòî÷íûõ ïàçóõ ìíå âèäèòñÿ âñïîìîãàòåëüíûì ìåòîäîì, íà ïðÿìóþ ëå÷åíèå, îñîáåííî îñòðîãî ñèíóñèòà, îò íåå íå çàâèñèò.
Ìîæåòå êèäàòü ïîìèäîðû.

Âîïðîñ ê çàðóáåæíûì ðåíòãåíîëîãàì - ÷àñòî ëè Âàøè êîëëåãè, îòîðèíîëàðèíãîëîãè, íàçíà÷àþò ðåíòãåíîãðàôèþ ïðèäàòî÷íûõ ïàçóõ è â êàêèõ ñëó÷àÿõ.

Êîììåíòàðèè ê ñîîáùåíèþ:
ArakancevUV îäîáðèë(à):
  #12  
Ñòàðûé 27.08.2008, 23:41
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ENT_1 Ïîñìîòðåòü ñîîáùåíèå
Âàøè îòâåòû íà ìîè ïîñòû (ðåïëèêè è ýìîöèè) íèêàê íå âÿæóòñÿ ñ äèñêóññèåé ïðèâåðæåíöåâ äîêàçàòåëüíîé ìåäèöèíû, è ñîâåðøåííî íå â ôîðìàòå âðà÷åáíûõ äèñêóññèé. Ê òîìó æå ÿ âàì íå ïîäðóæêà, ÷òîáû îòâå÷àòü â ïîäîáíîì ôàìèëüÿðíîì èëè äàæå âûñîêîìåðíîì òîíå.
Öèòàòà:
Ðåíòãåíîäèàãíîñòèêà - ýòî íå òîëüêî áàíàëüíûé íåíàâèñòíûé Âàì ðåíòãåí, ýòî åùå è ðåíòãåíîâñêàÿ êîìïüþòåðíàÿ òîìîãðàôèÿ.
ß ñêàæåì òàê ïðîäîëæèë â òîì æå òîíå, ìîæåò áûòü, íåìíîãî ñìÿã÷èâ.

Öèòàòà:
"Âî ïåðâûõ, îòêóäà Âû âçÿëè, ÷òî ó áîëüíîé èìåííî ôðîíòèò? Ýòî åùå íåèçâåñòíî. Ïîêà ìû èìååì äåëî ñ ñèíóñèòîì, íå áîëåå."
Åñëè ñèíóñèò è ôðîíòèò äëÿ Âàñ ðàçíûå ïîíÿòèÿ, òî òîãäà ìû òî÷íî ãîâîðèì íà ðàçíûõ ÿçûêàõ.
Íå ïåðåäåðãèâàéòå, êîëëåãà. Åñëè Âû ìîæåòå äèàãíîñòèðîâàòü ôðîíòèò ôèçèêàëüíî... Âû èëè âîëøåáíèê èëè ...
Ïîêà ðå÷ü øëà òîëüêî è ñèíóñèòå, áîëåå êîíêðåòíî ìû íå çíàåì.

Öèòàòà:
Ðåæèì äîçèðîâàíèÿ ( àçèòðîìèöèí)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Óñòàíàâëèâàþò èíäèâèäóàëüíî ñ ó÷åòîì íîçîëîãè÷åñêîé ôîðìû, òÿæåñòè òå÷åíèÿ çàáîëåâàíèÿ è ÷óâñòâèòåëüíîñòè âîçáóäèòåëÿ. Âçðîñëûì âíóòðü íàçíà÷àþò 0.25-1 ã 1 ðàç/ñóò; äåòÿì - 5-10 ìã/êã 1 ðàç/ñóò. Ïðîäîëæèòåëüíîñòü ïðèåìà 2-5 äíåé.
ëèáî ñìîòðèòå [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
"Íå ÷èòàéòå ñîâåòñêèõ ãàçåò" (ñ). ß ïîíÿòèÿ íå èìåþ îòêóäà ýòà èíôà â Âèäàëå... ñ÷èòàë ýòî èçäàíèå íàäåæíûì èñòî÷íèêîì. Îäíàêî, ñïðàâî÷íèê íå ÿâëÿåòñÿ îñíîâàíèåì íè äëÿ íàçíà÷åíèÿ ïðåïàðàòà íè äëÿ âûáîðà ñðîêà äëèòåëüíîñòè ïðèåìà.

Öèòàòà:
The course of treatment is usually 14 days. First-line therapy at most centers is usually amoxicillin or a macrolide antibiotic in patients allergic to penicillin because of the low cost, ease of administration, and low toxicity of these agents.
Èçìåíåí íà ìàêðîëèä, ò.ê. áîëüíàÿ ïðåðâàëà êóðñ "ôëåìî". Ïîëàãàþ, ýòî äîñòàòî÷íîå îñíîâàíèå íå íà÷èíàòü àìîêñèöèëëèí çàíîâî.

Íåìíîãî áîëåå î ðåíòãåíå. Â ïðåäîñòàâëåííîì Âàìè ðóêîâîäñòâå:
Öèòàòà:
Statement 1b. Radiographic Imaging and Acute Rhinosinusitis Clinicians should not obtain radiographic imaging for patients who meet diagnostic criteria for acute rhinosinusitis, unless a complication or alternative diagnosis is suspected. Recommendation against based on diagnostic studies with minor limitations and a preponderance of benefit over harm.
Ðå÷ü î òîì, ÷òî åñëè äèàãíîç ïîñòàâëåí êëèíè÷åñêè, òî ïîäòâåðæäàòü åãî ðåíòãåíîì íå íóæíî. À âîò åñëè åñòü ïîäîçðåíèÿ íà îñëîæíåíèÿ, íàïðèìåð, èëè ñîìíåíèÿ â ïîëüçó äðóãîãî çàáîëåâàíèÿ - òîëüêî òîãäà.


Íå âñåãäà ñëåäóåò ñðàçó æå íàçíà÷àòü àíòèáèîòèêè. Âûæèäàòåëüíî-íàáëþäàòåëüíàÿ òàêòèêà:
Statement 4. Watchful Waiting
Öèòàòà:
for Acute Bacterial Rhinosinusitis (ABRS)
Observation without use of antibiotics is an option for selected adults with uncomplicated ABRS who have mild illness (mild pain and temperature <38.3°C or 101°F) and assurance of follow-up. Option based on double-
blind randomized controlled trials with heterogeneity in diagnostic criteria and illness severity, and a relative balance of benefit and risk.
Ñïàñèáî, ãàéä äåéñòâèòåëüíî òîëêîâûé.
  #13  
Ñòàðûé 28.08.2008, 00:06
Àâàòàð äëÿ ENT_1
ENT_1 ENT_1 âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.07.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,066
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 378 ðàç(à) çà 355 ñîîáùåíèé
ENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâ. Morphey, ó Âàñ òîæå ïðîãðåññ íàëèöî, â ïëàíå òîíà îáùåíèÿ è ñîäåðæàíèÿ äèñêóññèè .
Êîãäà ñòàâèòñÿ äèàãíîç ñèíóñèò, òî âñåãäà ïîäðàçóìåâàåòñÿ êàêîé èìåííî.  èñòîðèè áîëåçíè Âû íèêîãäà íå âñòðåòèòå äèàãíîç "îñòðûé ðèíîñèíóñèò" çà èñêëþ÷åíèåì â êîíòåêñòå ÎÐÂÈ. Äèàãíîç äîëæåí â ñåáå ñîäåðæàòü ìàêñèìàëüíîå êîë-âî èíôîðìàöèè, áûòü ïàòîãåíåòè÷åñêèì: ïðîäîëæèòåëüíîñòü (îñòðûé, õðîíè÷åñêèé è ò.ï.), ëîêàëèçàöèþ (ãàéìîðèò, ôðîíòèò è ò.ï.), ýòèîëîãèþ - òîæå ÷àñòî îïóñêàåòñÿ(âèðóñíûé, áàêòåðèàëüíûé, ãðèáêîâûé), ñòàäèþ (ôîðìó) çàáîëåâàíèÿ (êàòàðàëüíûé, ãíîéíûé, ïîëèïîçíûé, êèñòîçíûé,), ïóòü ðàñïðîñòðàíåíèÿ (ðèíîãåííûé - ÷àñòî îïóñêàåòñÿ, îäîíòîãåííûé) è ò.ä.
Íàïðèìåð: îñòðûé ïðàâîñòîðîííèé ãíîéíûé ãåìèñèíóñèò, õðîíè÷åñêèé äâóñòîðîííèé ïîëèïîçíûé ãàéìîðîýòìîèäèò. Îñòðûé ëåâîñòîðîííèé ãíîéíûé ñôåíîèäèò.
È ÿ íå âîëøåáíèê, ìîé îïûò ïîçâîëÿåò ìíå ïîäîçðåâàòü ëîêàëèçàöèþ ïðîöåññà, à åñëè íåò - òî â ìîåì ðàñïîðÿæåíèè äîïîëíèòåëüíûå ìåòîäû îáñëåäîâàíèÿ.
×òî êàñàåòñÿ àçèòðîìèöèíà, åñëè âèäàëü âàì íå ïîäõîäèò, ìîæåò òîãäà ïîäîéäåò èíñòðóêöèÿ ê ïðåïàðàòó, êîòîðûé ïðîäàåòñÿ â ðîññèéñêèõ àïòåêàõ?
À ïðî âûæèäàòåëüíóþ òàêòèêó ÿ ïèñàëà, ìû åå òîæå ïðèìåíÿåì.

Êîììåíòàðèè ê ñîîáùåíèþ:
áðóêñà íå îäîáðèë(à): Íå íàäî ìåíòîðñêîãî òîíà. Â ïëàíå òîíà îáùåíèÿ è ñîäåðæàíèÿ äèñêóññèè Âû ëó÷øå íå ñòàíîâèòåñü.
  #14  
Ñòàðûé 28.08.2008, 00:17
Àâàòàð äëÿ Morphey
Morphey Morphey âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.07.2007
Ãîðîä: Lisbon
Ñîîáùåíèé: 1,839
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 369 ðàç(à) çà 285 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 8
Morphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMorphey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ENT_1 Ïîñìîòðåòü ñîîáùåíèå
Êîãäà ñòàâèòñÿ äèàãíîç ñèíóñèò, òî âñåãäà ïîäðàçóìåâàåòñÿ êàêîé èìåííî.  èñòîðèè áîëåçíè Âû íèêîãäà íå âñòðåòèòå äèàãíîç "îñòðûé ðèíîñèíóñèò" çà èñêëþ÷åíèåì â êîíòåêñòå ÎÐÂÈ. Äèàãíîç äîëæåí â ñåáå ñîäåðæàòü ìàêñèìàëüíîå êîë-âî èíôîðìàöèè, áûòü ïàòîãåíåòè÷åñêèì: ïðîäîëæèòåëüíîñòü (îñòðûé, õðîíè÷åñêèé è ò.ï.), ëîêàëèçàöèþ (ãàéìîðèò, ôðîíòèò è ò.ï.), ýòèîëîãèþ - òîæå ÷àñòî îïóñêàåòñÿ(âèðóñíûé, áàêòåðèàëüíûé, ãðèáêîâûé), ñòàäèþ (ôîðìó) çàáîëåâàíèÿ (êàòàðàëüíûé, ãíîéíûé, ïîëèïîçíûé, êèñòîçíûé,), ïóòü ðàñïðîñòðàíåíèÿ (ðèíîãåííûé - ÷àñòî îïóñêàåòñÿ, îäîíòîãåííûé) è ò.ä.
Íàïðèìåð: îñòðûé ïðàâîñòîðîííèé ãíîéíûé ãåìèñèíóñèò, õðîíè÷åñêèé äâóñòîðîííèé ïîëèïîçíûé ãàéìîðîýòìîèäèò. Îñòðûé ëåâîñòîðîííèé ãíîéíûé ñôåíîèäèò.
ß êîíå÷íî ïîíèìàþ, ÷òî Âàøà áîëüíèöà âïåðåäè ïëàíåòû âñåé. Îäíàêî, òàêèå ôîðìóëèðîâêè èñïîëüçóþòñÿ òîëüêî ó Âàñ.
Õîòåëîñü áû óâèäåòü ìíåíèå êîëëåã èç äðóãèõ ñòðàí, îäíàêî ó íàñ òàê íå ïðèíÿòî. È âñòðå÷àþ è ïèøó èìåííî òàê "î.ðèíîñèíóñèò". Ïîòîìó êàê ëîêàëèçàöèÿ èçíà÷àëüíî, áåç îñëîæíåíèé è ïîêàçàíèé äëÿ õèðóðãè÷. ëå÷åíèÿ íå ñòîëü âàæíà.
Åùå ðàç... êîãäà ïîñòóïàåò ïàöèåíò, Âû íå çíàåòå íè òî÷íóþ ýòèîëîãèþ, íè ëîêàëèçàöèþ, íè ñòàäèþ-ôîðìó(î ÷åì ý î âû è çà÷åì???). È â èäåàëå Âû ýòî âñå è íå óçíàåòå.

Öèòàòà:
È ÿ íå âîëøåáíèê, ìîé îïûò ïîçâîëÿåò ìíå ïîäîçðåâàòü ëîêàëèçàöèþ ïðîöåññà, à åñëè íåò - òî â ìîåì ðàñïîðÿæåíèè äîïîëíèòåëüíûå ìåòîäû îáñëåäîâàíèÿ.
Çà÷åì???
Öèòàòà:
×òî êàñàåòñÿ àçèòðîìèöèíà, åñëè âèäàëü âàì íå ïîäõîäèò, ìîæåò òîãäà ïîäîéäåò èíñòðóêöèÿ ê ïðåïàðàòó, êîòîðûé ïðîäàåòñÿ â ðîññèéñêèõ àïòåêàõ?
Íó ïðè ÷åì òóò èíñòðóêöèÿ...
  #15  
Ñòàðûé 28.08.2008, 00:27
Àâàòàð äëÿ ENT_1
ENT_1 ENT_1 âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.07.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,066
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 378 ðàç(à) çà 355 ñîîáùåíèé
ENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåENT_1 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âñÿ ðàçíèöà â òîì, ÷òî âû òåðàïåâò (?), à ÿ îòîëàðèíãîëîã. Ìû ðàáîòàåì ñ ýòèì äèàãíîçîì íà ðàçíûõ ñòàäèÿõ.  íàøèõ ïîëèêëèíèêàõ òåðàïåâòû òîæå ïèøóò î. ðèíîñèíóñèò. Âîò êîãäà ýòîò î. ðèíîñèíóñèò íå ïîääàåòñÿ ëå÷åíèþ, òîãäà áîëüíîé îêàçûâàåòñÿ â ðóêàõ ËÎÐ-âðà÷à, çàäà÷à êîòîðîãî ñïðàâèòüñÿ ñ çàáîëåâàíèåì è íåäîïóñòèòü îñëîæíåíèé (àáñöåññ ãîë. ìîçãà, ìåíèíãèòû, îðáèòàëüíûå îñëîæíåíèÿ, òðîìáîç êàâåðíîçíîãî ñèíóñà è ò.ä. è ò.ï.). Ýòè îñëîæíåíèÿ ìû ÷àñòî âèäèì, à âû?
Ïîýòîìó ìû î÷åíü îòâåòñòâåííî ïîäõîäèì ê ëå÷åíèþ ñèíóñèòîâ (ôðîíòèòîâ, ñôåíîèäèòîâ è ò.ä.), òàê æå êàê è çàðóáåæíûå êîëëåãè. Ìû ãîâîðèì ñåé÷àñ íå î íàñìîðêå.
À ÷òî êàñàåòñÿ àçèòðîìèöèíà, èíñòðóêöèÿ - ýòî òî, íà ÷òî ìîæíî ñîñëàòüñÿ.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Acute bacterial sinusitis 500 mg QD x 3 days
Êñòàòè, ñ äíåì ðîæäåíèÿ!

Êîììåíòàðèè ê ñîîáùåíèþ:
Rodionov îäîáðèë(à):
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 22:49.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.